Upload
karakoza
View
221
Download
0
Embed Size (px)
Citation preview
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 1/43
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 2/43
Pathology of BronchialPathology of BronchialAsthmaAsthma
BYBY
Dr. Amira Kamal El-Hawary
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 3/43
IntroductionIntroduction::
Non-Specific immunityNon-Specific immunityNeutrophils, MacrophagesNeutrophils, Macrophages
Humoral ImmunityHumoral ImmunityB lymphocytes - AntibodyB lymphocytes - Antibody
Cell mediated ImmunityCell mediated ImmunityT lymphocytes –T lymphocytes –
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 4/43
IntroductionIntroduction::
Primary response – slow, weak.Primary response – slow, weak.
Learning period, memory cells.Learning period, memory cells.
Secondary response – rapid,Secondary response – rapid,
strongstrong
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 5/43
Immune DisordersImmune Disorders:: Immunodeficiency disordersImmunodeficiency disorders
AIDS, antibody deficiencyAIDS, antibody deficiency Hypersensitivity Disorders (allergy)Hypersensitivity Disorders (allergy)
excessive or altered reaction to an antigen producingexcessive or altered reaction to an antigen producing
adverse effects on the body. it is classified into 4adverse effects on the body. it is classified into 4typestypes Type-I (IgE),Type-I (IgE),
Type II-IgG,Type II-IgG,
Type III-Immune complex,Type III-Immune complex, Type IV-Cell mediated.Type IV-Cell mediated.
Autoimmune disordersAutoimmune disorders SLE, Rheumatoid, Rheumatic fever.SLE, Rheumatoid, Rheumatic fever.
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 6/43
Type I hypersensitivity reactionType I hypersensitivity reaction(Atopy(Atopy((
--Pathogenesis:-Pathog
enesis:-- First exposure- First exposure to an antigento an antigen
stimulation of B-lymphocytes tostimulation of B-lymphocytes totransform to IgE secreting plasma cellstransform to IgE secreting plasma cells( helped by CD4+ T-lymphocytes)( helped by CD4+ T-lymphocytes)IgE binds to the surface of mast cellsIgE binds to the surface of mast cells
and basophilsand basophils
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 7/43
First exposure
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 8/43
Type I hypersensitivity reactionType I hypersensitivity reaction
--Second exposureSecond exposure to the same antigento the same antigenresults in cross-linking of Ig E on theresults in cross-linking of Ig E on thesurface of mast cellssurface of mast cellsDegranulation of the cells with releaseDegranulation of the cells with releaseof chemical mediatorsof chemical mediators
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 9/43
SECOND EXPOSUREFIRST EXPOSURE
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 10/43
Chronic obstructive pulmonaryChronic obstructive pulmonary
disease (COPDdisease (COPD(( COPD is a disease state characterized byCOPD is a disease state characterized by
airflow limitation that is not fullyairflow limitation that is not fullyreversible. The airflow limitation isreversible. The airflow limitation isusually both progressive and associatedusually both progressive and associatedwith an abnormal inflammatory responsewith an abnormal inflammatory responseof the lungs to particles or gases.of the lungs to particles or gases.
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 11/43
Obstructive Pulmonary DiseasesObstructive Pulmonary Diseases Classical COPDsClassical COPDs
EmphysemaEmphysema
Chronic BronchitisChronic Bronchitis
Bronchial AsthmaBronchial Asthma
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 12/43
Bronchial asthmaBronchial asthma
Increased responsiveness of theIncreased responsiveness of thebronchial tree to various stimuli thatbronchial tree to various stimuli thatresults inresults in paroxysms of Bronchospasmparoxysms of Bronchospasm
reversible bronchospasmreversible bronchospasm laterlaterchronic bronchial inflammation developchronic bronchial inflammation developand airflow is limited by bronchoconstriction,and airflow is limited by bronchoconstriction,mucus plugs, and increased inflammationmucus plugs, and increased inflammation andandobstructive lung disease developobstructive lung disease develop
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 13/43
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 14/43
Incidence of asthmaIncidence of asthma
It is a common disease affecting 5% ofIt is a common disease affecting 5% ofadults and 7-10% of childrenadults and 7-10% of children..
There has been a significant increase inThere has been a significant increase inthe incidence of asthma in thethe incidence of asthma in theWestern world in the past threeWestern world in the past threedecadesdecades
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 15/43
-- - Clinically , it is manifested byClinically , it is manifested byrecurrent episodes of wheezing,recurrent episodes of wheezing,breathlessness, and cough that isbreathlessness, and cough that isat least partly reversible, eitherat least partly reversible, eitherspontaneously or with treatment.spontaneously or with treatment.
- Between the attacks, patientsBetween the attacks, patientsmay be virtually asymptomaticmay be virtually asymptomatic
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 16/43
What are the Triggering FactorsWhat are the Triggering Factors??
Domestic dust mitesDomestic dust mites Air pollutionAir pollution Tobacco smokeTobacco smoke OccupationalOccupational
irritantsirritants CockroachCockroach
Animal with furAnimal with fur PollenPollen
Respiratory (viral)Respiratory (viral)infectionsinfections
Chemical irritantsChemical irritants Strong emotionalStrong emotional
expressionsexpressions Drugs ( aspirin,Drugs ( aspirin,
beta blockers)beta blockers)
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 17/43
PathogenesisPathogenesis
Common denominator underlying all forms of Common denominator underlying all forms of asthma is an exaggerated bronchoconstrictor asthma is an exaggerated bronchoconstrictor
response (airwayresponse (airway hyperresponsivenesshyperresponsiveness) to a) to a
variety of stimuli. Airway hyperresponsivenessvariety of stimuli. Airway hyperresponsivenesscan be readily demonstrated in the form of can be readily demonstrated in the form of
increased sensitivity to bronchoconstrictive agentsincreased sensitivity to bronchoconstrictive agents
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 18/43
PathogenesisPathogenesis•
Most current evidence suggests thatMost current evidence suggests that bronchial bronchial inflammation is the substrate for hyperresponsiveness.inflammation is the substrate for hyperresponsiveness.
• What causes the bronchial inflammation?What causes the bronchial inflammation? In extrinsicIn extrinsic(allergic) asthma, it is readily explained by type I(allergic) asthma, it is readily explained by type Ihypersensitivity reactions, but the cause is much lesshypersensitivity reactions, but the cause is much lessclear in patients with intrinsic asthmaclear in patients with intrinsic asthma
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 19/43
INFLAMMATIONINFLAMMATION
Airflow Limitation
SYMPTOMSCough Wheeze
Dyspnoea
TRIGGERSAllergens, Exercise,
Cold Air, SO2 Particulates
PathogenesisPathogenesis
Type I hypersensitivity
INDUCERS
Allergens, Air pollutants,
Virus infections
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 20/43
Pathogenetic TypesPathogenetic Types
AtopicAtopic andand non atopicnon atopic asthmaasthma
•There are two types of asthma,There are two types of asthma,atopicatopic ( with( with evidence of allergen
sensitization))non atopicnon atopic (without(without evidence ofallergen sensitization))
•This distinction is useful from thepoint of pathophysiology, but inclinical practice it is not always
possible to classify asthma.
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 21/43
SECOND EXPOSUREFIRST EXPOSURE
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 22/43
Bronchial Asthma - PathophysiologyBronchial Asthma - Pathophysiology
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 23/43
--Pathogenesis of extrinsic (atopic) asthmaPathogenesis of extrinsic (atopic) asthma
11--Meeting the specific allergen causes sensitizationMeeting the specific allergen causes sensitizationof CD4+ (T н2) cells resulting in release ofof CD4+ (T н2) cells resulting in release ofcytokines (IL-4,5, and 13).cytokines (IL-4,5, and 13).
2- IL-4,5 and 13 cause2- IL-4,5 and 13 cause
a. Stimulation of IgE productiona. Stimulation of IgE productionb. Growth of mast cells.b. Growth of mast cells. 3- Meeting the specific allergen for the second3- Meeting the specific allergen for the secondtime results in an immune reaction which passestime results in an immune reaction which passes
into two phasesinto two phasesi- An early phase starting 30-60 min.afteri- An early phase starting 30-60 min.afterinhalation of the antigen theninhalation of the antigen thenii- A late phase develops after 4-8 hoursii- A late phase develops after 4-8 hours..
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 24/43
Pathogenesis of extrinsic (atopic) asthmaPathogenesis of extrinsic (atopic) asthma
44--During theDuring the
early phaseearly phase
,,
primary mediators areprimary mediators arereleased. They includereleased. They include- Leucotriens which are- Leucotriens which aresythesized from phospholipidsythesized from phospholipid
by phospholipase enzymeby phospholipase enzyme- Histamine- Histamine- Platelet –Activating Factor- Platelet –Activating Factor
--
These mediators produce …..These mediators produce …..bronchoconstriction,bronchoconstriction,vasodilatation, increasedvasodilatation, increasedvascular permeability andvascular permeability andincreased mucin secretionincreased mucin secretion..
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 25/43
Pathogenesis of extrinsic (atopic) asthmaPathogenesis of extrinsic (atopic) asthma
55--During theDuring the late phaselate phase secondarysecondarymediators are released includingmediators are released including- Eosinophil and neutrophil- Eosinophil and neutrophilchemotactic factorschemotactic factors- IL-4 &5- IL-4 &5
- Platelet Activating factor- Platelet Activating factor
- These mediators- These mediatorsproduce…..produce…..eosinophileosinophil and neutrophiland neutrophilinfiltration to the site of the lesioninfiltration to the site of the lesionthese cells producethese cells produce
a- More mediators that activatea- More mediators that activatemast cells and intensify the initialmast cells and intensify the initialresponse.response.b. Epithelial cell damageb. Epithelial cell damage..
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 26/43
Pathogenesis - Atopic AsthmaPathogenesis - Atopic Asthma::
Airway inflammation with mucosal oedemaAirway inflammation with mucosal oedema
Mucus pluggingMucus plugging
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 27/43
Pathogenesis of non atopicPathogenesis of non atopicasthmaasthma
In which the triggering factors include aspirin;In which the triggering factors include aspirin; pulmonary infections, especially those caused by pulmonary infections, especially those caused byviruses; cold; psychological stress; exercise; andviruses; cold; psychological stress; exercise; andinhaled irritants such as ozone and sulfur dioxide.inhaled irritants such as ozone and sulfur dioxide.
These agents increase airway hyperreactivity in bothThese agents increase airway hyperreactivity in bothnormal and asthmatic subjects. In the latter, however,normal and asthmatic subjects. In the latter, however,the bronchial response, manifested as spasm, is muchthe bronchial response, manifested as spasm, is muchmore severe and sustainedmore severe and sustained
There is usually no personal or family history of There is usually no personal or family history of allergic manifestations, and serum IgE levels areallergic manifestations, and serum IgE levels are
normalnormal..
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 28/43
ExtrinsicExtrinsic
--Type-I (IgE-mediated)Type-I (IgE-mediated)hyper-sensitivity orhyper-sensitivity orallergic reactionallergic reaction
--Triggered byTriggered byenvironmental antigensenvironmental antigens
(dust, pollens, food(dust, pollens, food, ..(, ..(
--Family history ofFamily history of AtopyAtopy
--Begins in childhoodBegins in childhood..
IntrinsicIntrinsic
--Not allergicNot allergic
--Triggered byTriggered byrespiratory tractrespiratory tractinfections &drugsinfections &drugs
(aspirin(aspirin(.(.
--No family historyNo family history
Bronchial Asthma
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 29/43
Lung Morphology in AsthmaLung Morphology in Asthma
Mucous pluggingMucous plugging
BronchospasmBronchospasm
Over inflationOver inflation
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 30/43
Lung Hyperinflation in AsthmaLung Hyperinflation in Asthma
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 31/43
Thick bronchi with MucousThick bronchi with Mucous
plugsplugs
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 32/43
Asthma -Asthma - Microscopic PathologyMicroscopic Pathology
PatchyPatchy necrosisnecrosis of epitheliumof epithelium Sub-mucosalSub-mucosal glandular glandular hyperplasiahyperplasia
Hypertrophy of bronchialHypertrophy of bronchial smoothsmooth musclemuscle EosinophilsEosinophils,, mastmast cellscells;; lymphocytelymphocyte MucousMucous plugs plugs, Whorled mucous plugs, Whorled mucous plugs
((Curschmann’s spiralsCurschmann’s spirals)) Debris of eosinophils (Debris of eosinophils (Charcot-LeydenCharcot-Leyden
crystalscrystals
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 33/43
Microscopic PathologyMicroscopic Pathology
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 34/43
Asthma Microscopic PathologyAsthma Microscopic Pathology
Obstructed
Inflammed
Bronchi
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 35/43
Asthma - Bronchial morphologyAsthma - Bronchial morphology
inflammationinflammation
Gland hyperplasiaGland hyperplasia
Mucous plug inMucous plug inlumenlumen
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 36/43
Inflammation epithelial
damage
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 37/43
Eosinophils in AsthmaEosinophils in Asthma::
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 38/43
Curschmann's spiralsCurschmann's spirals::
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 39/43
Bronchial AsthmaBronchial Asthma
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 40/43
ComplicationsComplications
1. Bronchpneumonia1. Bronchpneumonia
2. Emphysema2. Emphysema
3. Rarely Death may occur in status3. Rarely Death may occur in statusasthamaticus.asthamaticus.
4. Massive Lung Collapse due to bronchial4. Massive Lung Collapse due to bronchial
obstruction by the mucus plug.obstruction by the mucus plug.
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 41/43
Immunological MechanismsImmunological Mechanisms
TypeType ΙΙ hypersensitivity - allergen binds to IgE onhypersensitivity - allergen binds to IgE onsurface of mast cellssurface of mast cells
Degranulation (histamine)Degranulation (histamine)
muscle spasmmuscle spasm inflammatory cell influx (eosinophils)inflammatory cell influx (eosinophils)
mucosal inflammation/oedemamucosal inflammation/oedema
Inflammatory infiltrate tends to chronicityInflammatory infiltrate tends to chronicity
8/3/2019 Pathology of Bronchial Asthma 2011
http://slidepdf.com/reader/full/pathology-of-bronchial-asthma-2011 42/43
• Eosinophils Eosinophils are key inflammatory cells foundare key inflammatory cells found
in asthma.in asthma.
• Airway remodeling (basement membraneAirway remodeling (basement membrane
thickening and hypertrophy of bronchialthickening and hypertrophy of bronchial
smooth muscle) adds to the element of smooth muscle) adds to the element of
obstructive disease.obstructive disease.